One Percent Tenofovir Applied Topically to Humanized BLT Mice and Used According to the CAPRISA 004 Experimental Design Demonstrates Partial Protection from Vaginal HIV Infection, Validating the BLT Model for Evaluation of New Microbicide CandidatesPaul W. Denton, J. Víctor García, Francisco Martinez-Torres et al.|Journal of Virology|2011Cited by 137